Operating Cash Flow: $19 million in Q4 ... Bioventus Inc (NASDAQ:BVS) reported a strong financial performance in 2024, with double-digit organic revenue growth in all four quarters.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback